METTL14 and hepatocellular carcinoma: reported that METTL14‐knockdown GSCs showed less demethylation changes as compared to METTL3‐knockdown GSCs.49 For hepatocellular carcinoma (HCC), the METTL14 expression and m6A level exhibited a converse tendency with the development of HCC, particularly in metastatic HCC.